A committee appointed to review the National List of
Essential Medicines is yet to submit their report, said State Minister of
Chemicals and Fertilizers Hans Raj Gangaram Ahir in Parliament.
Ministry of Health and Family Welfare has set up a
core committee for revision of National List of Essential Medicine (NLEM) 2011
in which both the Department of Pharmaceutical and NPPA are represented.
There are 680 drug formulations related to 348 bulk
drugs listed in NLEM by National Pharmaceutical Pricing Authority (NPPA).
He further informed that over the pricing of the
patented drugs in India, an inter-ministerial committee has been set up to look
into the issues.
"To address the issue of price negotiation
mechanism for patented drugs, an inter-ministerial committee of joint secretaries
has been set up on November 7, 2011 to look into the issues and to suggest ways
and means to fix prices of patented drugs in the country," Ahir informed.
He further informed that the government has received
two requests by the private players to manufacture patented drugs under the
compulsory licensing and in which drug maker Natco's plea has been approved by
the Controller General of Patents designs and Trade Mark (CGPDTM).
No comments:
Post a Comment